Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Chemotherapy-induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Interventions
DEVICE

Scrambler Therapy

Participants will attend 10 consecutive weekday 45-minute sessions of scrambler therapy.

OTHER

Sham/No Intervention

Participants will be blinded as to which arm they are in (experimental vs. sham comparator), and as such, participants in the sham comparator arm will attend 10 consecutive weekday 45-minute sessions of sham scrambler therapy. In the sham comparator arm, participants will NOT receive a therapeutic level of scrambler therapy.

Trial Locations (1)

44195

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland

All Listed Sponsors
collaborator

VelaSano

UNKNOWN

lead

Case Comprehensive Cancer Center

OTHER

NCT07219472 - Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy | Biotech Hunter | Biotech Hunter